Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last 5,300 KRW
Change Today +20.00 / 0.38%
Volume 50.4K
As of 2:28 AM 04/17/15 All times are local (Market data is delayed by at least 15 minutes).

panagene inc (046210) Snapshot

Open
5,300
Previous Close
5,280
Day High
5,400
Day Low
5,260
52 Week High
09/16/14 - 6,580
52 Week Low
06/24/14 - 3,050
Market Cap
142.1B
Average Volume 10 Days
84.8K
EPS TTM
-64.00
Shares Outstanding
26.8M
EX-Date
12/28/07
P/E TM
--
Dividend
--
Dividend Yield
--
Current Stock Chart for PANAGENE INC (046210)

Related News

No related news articles were found.

panagene inc (046210) Related Businessweek News

No Related Businessweek News Found

panagene inc (046210) Details

Panagene Inc. produces and sells molecular diagnostic products. The company provides diagnostic products, such as PANAMutyper R to detect lung and colorectal cancer biomarkers, such as EGFR, KRAS, and NRAS; PNAClamp mutation detection kits; PANArray human papillomavirus genotyping chips; and PANA qPCR mycobacteria tuberculosis and nontuberculous mycobacteria detection kits. It also offers PNA oligomers, PNA FISH probes, and PNAs miRNA inhibitor; and Fmoc PNA monomers. The company was formerly known as Koram Panagene Ltd. and changed its name to Panagene Inc. in January 2009. Panagene Inc. was founded in 2001 and is headquartered in Daejeon, South Korea.

63 Employees
Last Reported Date: 11/14/13
Founded in 2001

panagene inc (046210) Top Compensated Officers

No compensation data is available at this time for the top officers at this company.

Executives, Board Directors

panagene inc (046210) Key Developments

Panagene Inc., Annual General Meeting, Mar 27, 2015

Panagene Inc., Annual General Meeting, Mar 27, 2015., at 10:00 Korea Standard Time. Location: panajin Co., Ltd. Headquarters 1st floor conference room. Agenda: To consider and approve the and business report and statement of financial statements: to approve appointment of in house directors of the company: to approve remuneration limit; to consider and approve the audit fee limit; and to approve stock option grant.

PANAGENE Inc., Annual General Meeting, Mar 28, 2014

PANAGENE Inc., Annual General Meeting, Mar 28, 2014., at 10:00 Korea Standard Time. Location: Head Office 1st Floor Conference Room panajin. Agenda: To consider and approve the audit reports and business report; to consider and approve the balance sheet, income statement, statement of financial position: approve of articles; to consider and approve election of directors of the company: outside directors; to consider and approve the directors remuneration limit; to consider and approve the audit fee limit; and to consider and approve the other references concerning investment decisions.

PANAGENE Inc. Reports Earnings Results for the Year Ended Dec. 31, 2012

PANAGENE Inc. reported earnings results for the year ended Dec. 31, 2012. For the year, the company reported revenue of KRW 28,641,189,233, operating loss of KRW 4,259,857,236, loss before tax of KRW 7,438,135,175 and net loss of KRW 7,342,372,347 compared to revenue of KRW 40,731,376,760, operating income of KRW 335,423,245, loss before tax of KRW 615,525,776 and net loss of KRW 1,592,465,302 reported in the same period last year. Basic loss per share was KRW 29,900.0 against KRW 2,500.0 reported last year. Cash flows from operating activities were KRW 4,813,131,319 against cash used in operating activities of KRW 3,681,969,677 reported last year. Purchase of property, plant and equipment was KRW 115,939,090 against KRW 1,309,786,938 reported last year. Purchase of intangible assets was KRW 698,151,740 against KRW 851,458,710 reported last year. Negative return on assets was 28.79% against 3.75% reported last year.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
046210:KS 5,300.00 KRW +20.00

046210 Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for 046210.
View Industry Companies
 

Industry Analysis

046210

Industry Average

Valuation 046210 Industry Range
Price/Earnings NM Not Meaningful
Price/Sales 4.7x
Price/Book 12.7x
Price/Cash Flow NM Not Meaningful
TEV/Sales 4.5x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact PANAGENE INC, please visit www.panagene.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.